Pete Smith, PhD
Chief Executive OfficerPete Smith, Chief Executive Officer
MA and PhD in Biochemistry from University of Cambridge
Top-rated European healthcare analyst with UBS and HSBC
Founder and CFO of Onyvax, a venture-backed cancer immunotherapy company
CEO of AMRAD & Alchemia, publicly listed Australian biotech companies.
Matt Beasley
Chief Scientific OfficerMatt Beasley, Chief Scientific Officer
Over 20 years laboratory experience.
CSO and co-founder of Affinity BIO.
CSO and co-founder of lab reagents company Alchemy Biosciences.
Inventor on all Affinity Patents.
Ben Kiefel, PhD
Chief Operating OfficerBen Kiefel, Chief Operating Officer
PhD in Evolutionary Molecular Biology
COO and co-founder of Affinity BIO
CEO and co-founder of lab reagents company Alchemy Biosciences
Inventor on all Affinity Patents.